CRISPR therapy for rare blood disease delivers “life-changing” results
New data from the United States’ first CRISPR gene editing clinical trial indicates the treatment is safe and effective more than two years after initial dosing. Targeting a pair of rare genetic blood diseases, the experimental therapy has so far been … Continue reading CRISPR therapy for rare blood disease delivers “life-changing” results